The purpose of this study was to analyze the expression of COX-2 and PD-L1 in a series of primary melanomas and lymph node metastases in order to establish their prognostic value and provide information on the possibility of adopting combined therapeutic strategies. The gene discussed is PTGS2; the disease is melanoma.